IP Library Granted Patent US 6,939,897
Granted Patent B2
US 6,939,897 · App. 10/892,164 · Granted Sep 6, 2005

Method and composition for inhibiting arteriosclerosis

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,939,897
App. No.
10/892,164
Granted
Sep 6, 2005
Kind
B2
Abstract

The present invention has for its object to provide a method and a composition for achieving a more efficient recovery of the antioxidant activity of plasma LDL, or even augmentation thereof, which has been depressed by the use of an antihyperlipidemic or cholesterol-lowering drug to thereby insure a potentiated antiarteriosclerotic efficacy. A method for inhibiting arteriosclerosis, which comprises using a combination of a cholesterol-lowering agent and a reduced coenzyme Q 10 represented by the following formula (1), and a composition for inhibiting arteriosclerosis containing both a cholesterol-lowering agent and said reduced coenzyme Q 10 .

Claims (6)

1. A method for enhancing LDL antioxidant activity

which comprises administering to a subject a combination of a cholesterol-lowering agent and a reduced coenzyme Q10 represented by the following formula (1):

in the formula, n is 10;

wherein a ratio of the cholesterol-lowering agent to the reduced coenzyme Q10 is 1:10 to 10:1 by weight.

2. The method according to claim 1 ,

wherein the cholesterol-lowering agent is a hydroxymethylglutaryl-CoA reductase inhibitor.

Assignments (1)
CHANGE OF ADDRESS Recorded Jan 15, 2014
From: KANEKA CORPORATION
To: KANEKA CORPORATION
Reel/Frame 032019/0901 →